Glenmark gets US FDA nod for marketing oxcarbazapine tabs (PharmaBiz)
Glenmark gets US FDA nod for marketing oxcarbazapine tabs (PharmaBiz)
Glenmark Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for the marketing the first generic version of trileptal (Oxcarbazepine). The approval is for marketing oxcarbazapine tablets in three strengths 150 mg, 300 mg and 600 mg.